The neuroendocrine hormone amylin, also known as islet amyloid polypeptide, is co-localized, co-packaged and cosecreted with insulin from adult pancreatic islet β cells to maintain glucose homeostasis. Specifically, ...The neuroendocrine hormone amylin, also known as islet amyloid polypeptide, is co-localized, co-packaged and cosecreted with insulin from adult pancreatic islet β cells to maintain glucose homeostasis. Specifically, amylin reduces secretion of nutrient-stimulated glucagon, regulates blood pressure with an effect on renin-angiotensin system, and delays gastric emptying. The physiological actions of human amylin attribute to the conformational α-helix monomers whereas the misfolding instable oligomers may be detrimental to the islet β cells and further transform to β-sheet fibrils as amyloid deposits. No direct evidence proves that the amylin fibrils in amyloid deposits cause diabetes. Here we also have performed a systematic review of human amylin gene changes and reported the S20 G mutation is minor in the development of diabetes. In addition to the metabolic effects, human amylin may modulate autoimmunity and innate inflammation through regulatory T cells to impact on both human type 1 and type 2 diabetes.展开更多
Alzheimer disease(AD) and typeⅡdiabetes mellitus(DM2) are the most common disease in aging people,with β-amyloid and amylin accumulation respectively.Studies have shown more and more correlations between these two d...Alzheimer disease(AD) and typeⅡdiabetes mellitus(DM2) are the most common disease in aging people,with β-amyloid and amylin accumulation respectively.Studies have shown more and more correlations between these two diseases,and amylin oligomerization in the brain provided a novel risk target for developing AD.Although cumulative studies reported that amylin aggregation induced cytotoxicity in pancreatic beta cells by altering Ca2+homeostasis,fewer studies investigated the effect of amylin on hippocampal neuron.To address this question,it was investigated the effect of amylin on primary cultured rat hippocampal neurons by calcium imaging and whole-cell patch clamp recording in this study,while the results revealed that human amylin(hAmylin) but not rat amylin or pramlintide(hAmylin analgue) produced a rapid increase in intracellular calcium in a dose dependent manner.This effect relied on extracellular calcium and not abolished by amylin receptor antagonist AC187.Additionally,the calcium increase induced by hAmylin was dependent onvoltage-gated Ca2+channels,especially L-type Ca2+channel activation.In whole-cell recording hAmylin could depolarize membrane potential and increase the cell exitability.Moreover,application of transient receptor potential vanilloid(TRPV) antagonist ruthenium red could abolish part of the intracellular calcium increase.Single cell RT-PCR revealed that TRPV4 mRNA expressed in most of the reactive neuron and selective TRPV4 antagonist HC067047 inhibited the intacellular calcium increasing.These results indicated that hAmylin aggregation precipitating on the neuron membrane activated TRPV4 channels and then triggered membrane voltage gated calcium channel opening followed by membrane depolarization,expressing that TRPV4 is a key molecular target for the cytotoxic effect of hAmylin on cultured neurons.展开更多
In the present study, we investigate effect of amylin on the insulin sensitivity of rat skeletal muscle extensor digitorum longus (EDL) using in vitro intact muscle incubation in combination with metabolic radioactive...In the present study, we investigate effect of amylin on the insulin sensitivity of rat skeletal muscle extensor digitorum longus (EDL) using in vitro intact muscle incubation in combination with metabolic radioactive labeling. The molecular basis of the amylin action was further examined using proteomic analysis. In particular, proteins of interest were characterized using an integrated microcharacterization procedure that involved in-gel trypsin digestion, organic solvent extraction, high performance liquid chromatography separation, microsequencing and microsequence analysis. We found that amylin significantly decreased the insulin-stimulated glucose incorporation into glycogen (p < 0.01) and produced a protein spot of approximately 20 ku in size. This amylin responsive protein (hereby designated as amylin responsive protein 1, APR1) was identified to be protein p20. Moreover, ARP1 spots on gels were found to consistently produce a corresponding radioactive spot on X-ray films in 32Pi but not in 35S-methionine labeling experiments. In conclusion, our results showed that in vitro amylin concomitantly evoked the production of ARP1 and caused insulin resistance in EDL muscle. It is suggested that protein p20 may be involved in amylin signal transduction and the appearance of ARP1 may be a step in a molecular pathway leading to the development of insulin resistance. ARP1 might therefore be a useful molecular marker for amylin action, insulin resistance and Type 2 diabetes.展开更多
Objective:In the present study, the protein structure model of human amylin was generated to understand the protein's structure, function and mechanism of the action. Methods: The stereo chemical quality of the pr...Objective:In the present study, the protein structure model of human amylin was generated to understand the protein's structure, function and mechanism of the action. Methods: The stereo chemical quality of the protein model was checked by usingin silico analysis withSWISSMODEL,SOPMA,PROCHECK, ProSA andQMEAN servers. Results:The 66.7% residues in the core region of Ramachandran plot showing high accuracy of protein model and the QMEAN Z score of –6.57 indicates the overall model quality of amylin protein. Conclusions: These results may be helpful for further investigation on developing target molecules for amylin proteins that play a key role in type 2 diabetes.展开更多
Co-secretion with insulin,highly amyloidogenic human amylin is considered to contribute to the initiation and progression of diabetic heart complications,despite other situations such as hypertension and atheroscleros...Co-secretion with insulin,highly amyloidogenic human amylin is considered to contribute to the initiation and progression of diabetic heart complications,despite other situations such as hypertension and atherosclerosis.In response to insulin resistance,hyperinsulinemia,and consequently hyperamylinemia,is common in prediabetic patients,where highly concentrated amylin is prone to form amylin oligomers,which further assemble into fibrils and amyloids with high b-sheet content.The infusion and deposition of oligomeric amylin in myocytes cause a series of consequences,including cytosolic Ca^(2+)dysregulation,calmodulin activation,myocyte hypertrophy,and ventricular stiffness,eventually leading to heart failure.In this review,we present the latest reports of amylin-related heart complications,provide new insights,and state the underlying pathogenesis,diagnosis,possible treatment,and prevention of diabetic cardiomyopathy.展开更多
Type 2 diabetes mellitus patients have a markedly higher risk of developing dementia.While multiple factors contribute to this predisposition,one of these involves the increased secretion of amylin,or islet amyloid po...Type 2 diabetes mellitus patients have a markedly higher risk of developing dementia.While multiple factors contribute to this predisposition,one of these involves the increased secretion of amylin,or islet amyloid polypeptide,that accompanies the pathophysiology of type 2 diabetes mellitus.Islet amyloid polypeptide accumulation has undoubtedly been implicated in various forms of dementia,including Alzheimer’s disease and vascular dementia,but the exact mechanisms underlying islet amyloid polypeptide’s causative role in dementia are unclear.In this review,we have summarized the literature supporting the various mechanisms by which islet amyloid polypeptide accumulation may cause neuronal damage,ultimately leading to the clinical symptoms of dementia.We discuss the evidence for islet amyloid polypeptide deposition in the brain,islet amyloid polypeptide interaction with other amyloids implicated in neurodegeneration,neuroinflammation caused by islet amyloid polypeptide deposition,vascular damage induced by islet amyloid polypeptide accumulation,and islet amyloid polypeptide-induced cytotoxicity.There are very few therapies approved for the treatment of dementia,and of these,clinical responses have been controversial at best.Therefore,investigating new,targetable pathways is vital for identifying novel therapeutic strategies for treating dementia.As such,we conclude this review by discussing islet amyloid polypeptide accumulation as a potential therapeutic target not only in treating type 2 diabetes mellitus but as a future target in treating or even preventing dementia associated with type 2 diabetes mellitus.展开更多
文摘The neuroendocrine hormone amylin, also known as islet amyloid polypeptide, is co-localized, co-packaged and cosecreted with insulin from adult pancreatic islet β cells to maintain glucose homeostasis. Specifically, amylin reduces secretion of nutrient-stimulated glucagon, regulates blood pressure with an effect on renin-angiotensin system, and delays gastric emptying. The physiological actions of human amylin attribute to the conformational α-helix monomers whereas the misfolding instable oligomers may be detrimental to the islet β cells and further transform to β-sheet fibrils as amyloid deposits. No direct evidence proves that the amylin fibrils in amyloid deposits cause diabetes. Here we also have performed a systematic review of human amylin gene changes and reported the S20 G mutation is minor in the development of diabetes. In addition to the metabolic effects, human amylin may modulate autoimmunity and innate inflammation through regulatory T cells to impact on both human type 1 and type 2 diabetes.
文摘Alzheimer disease(AD) and typeⅡdiabetes mellitus(DM2) are the most common disease in aging people,with β-amyloid and amylin accumulation respectively.Studies have shown more and more correlations between these two diseases,and amylin oligomerization in the brain provided a novel risk target for developing AD.Although cumulative studies reported that amylin aggregation induced cytotoxicity in pancreatic beta cells by altering Ca2+homeostasis,fewer studies investigated the effect of amylin on hippocampal neuron.To address this question,it was investigated the effect of amylin on primary cultured rat hippocampal neurons by calcium imaging and whole-cell patch clamp recording in this study,while the results revealed that human amylin(hAmylin) but not rat amylin or pramlintide(hAmylin analgue) produced a rapid increase in intracellular calcium in a dose dependent manner.This effect relied on extracellular calcium and not abolished by amylin receptor antagonist AC187.Additionally,the calcium increase induced by hAmylin was dependent onvoltage-gated Ca2+channels,especially L-type Ca2+channel activation.In whole-cell recording hAmylin could depolarize membrane potential and increase the cell exitability.Moreover,application of transient receptor potential vanilloid(TRPV) antagonist ruthenium red could abolish part of the intracellular calcium increase.Single cell RT-PCR revealed that TRPV4 mRNA expressed in most of the reactive neuron and selective TRPV4 antagonist HC067047 inhibited the intacellular calcium increasing.These results indicated that hAmylin aggregation precipitating on the neuron membrane activated TRPV4 channels and then triggered membrane voltage gated calcium channel opening followed by membrane depolarization,expressing that TRPV4 is a key molecular target for the cytotoxic effect of hAmylin on cultured neurons.
文摘In the present study, we investigate effect of amylin on the insulin sensitivity of rat skeletal muscle extensor digitorum longus (EDL) using in vitro intact muscle incubation in combination with metabolic radioactive labeling. The molecular basis of the amylin action was further examined using proteomic analysis. In particular, proteins of interest were characterized using an integrated microcharacterization procedure that involved in-gel trypsin digestion, organic solvent extraction, high performance liquid chromatography separation, microsequencing and microsequence analysis. We found that amylin significantly decreased the insulin-stimulated glucose incorporation into glycogen (p < 0.01) and produced a protein spot of approximately 20 ku in size. This amylin responsive protein (hereby designated as amylin responsive protein 1, APR1) was identified to be protein p20. Moreover, ARP1 spots on gels were found to consistently produce a corresponding radioactive spot on X-ray films in 32Pi but not in 35S-methionine labeling experiments. In conclusion, our results showed that in vitro amylin concomitantly evoked the production of ARP1 and caused insulin resistance in EDL muscle. It is suggested that protein p20 may be involved in amylin signal transduction and the appearance of ARP1 may be a step in a molecular pathway leading to the development of insulin resistance. ARP1 might therefore be a useful molecular marker for amylin action, insulin resistance and Type 2 diabetes.
文摘Objective:In the present study, the protein structure model of human amylin was generated to understand the protein's structure, function and mechanism of the action. Methods: The stereo chemical quality of the protein model was checked by usingin silico analysis withSWISSMODEL,SOPMA,PROCHECK, ProSA andQMEAN servers. Results:The 66.7% residues in the core region of Ramachandran plot showing high accuracy of protein model and the QMEAN Z score of –6.57 indicates the overall model quality of amylin protein. Conclusions: These results may be helpful for further investigation on developing target molecules for amylin proteins that play a key role in type 2 diabetes.
基金This work was supported by research grants from the National Natural Science Foundation of China(82070392 and 81900332).
文摘Co-secretion with insulin,highly amyloidogenic human amylin is considered to contribute to the initiation and progression of diabetic heart complications,despite other situations such as hypertension and atherosclerosis.In response to insulin resistance,hyperinsulinemia,and consequently hyperamylinemia,is common in prediabetic patients,where highly concentrated amylin is prone to form amylin oligomers,which further assemble into fibrils and amyloids with high b-sheet content.The infusion and deposition of oligomeric amylin in myocytes cause a series of consequences,including cytosolic Ca^(2+)dysregulation,calmodulin activation,myocyte hypertrophy,and ventricular stiffness,eventually leading to heart failure.In this review,we present the latest reports of amylin-related heart complications,provide new insights,and state the underlying pathogenesis,diagnosis,possible treatment,and prevention of diabetic cardiomyopathy.
基金supported by The Mike Hogg FundBaylor College of Medicine Medical Scientist Training Program,NICHD R01HD099252(to RJP)and R01HD098131(to RJP)the NHLBI T32 HL092332(to ASB)。
文摘Type 2 diabetes mellitus patients have a markedly higher risk of developing dementia.While multiple factors contribute to this predisposition,one of these involves the increased secretion of amylin,or islet amyloid polypeptide,that accompanies the pathophysiology of type 2 diabetes mellitus.Islet amyloid polypeptide accumulation has undoubtedly been implicated in various forms of dementia,including Alzheimer’s disease and vascular dementia,but the exact mechanisms underlying islet amyloid polypeptide’s causative role in dementia are unclear.In this review,we have summarized the literature supporting the various mechanisms by which islet amyloid polypeptide accumulation may cause neuronal damage,ultimately leading to the clinical symptoms of dementia.We discuss the evidence for islet amyloid polypeptide deposition in the brain,islet amyloid polypeptide interaction with other amyloids implicated in neurodegeneration,neuroinflammation caused by islet amyloid polypeptide deposition,vascular damage induced by islet amyloid polypeptide accumulation,and islet amyloid polypeptide-induced cytotoxicity.There are very few therapies approved for the treatment of dementia,and of these,clinical responses have been controversial at best.Therefore,investigating new,targetable pathways is vital for identifying novel therapeutic strategies for treating dementia.As such,we conclude this review by discussing islet amyloid polypeptide accumulation as a potential therapeutic target not only in treating type 2 diabetes mellitus but as a future target in treating or even preventing dementia associated with type 2 diabetes mellitus.
